From Russ Grant, BioAssay Toxicity Testing
Glenn Crocker’s article makes an interesting point about the future of biotechnology-based companies and the involvement of venture capitalists (19 July, p 52). Venture capitalists usually only get involved in the later stages of company development, but their input in biotech start-ups would be very beneficial.
However, there is a major stumbling block: the academic who started the company would have to relinquish control at an earlier stage. But one only needs to look across the Atlantic to appreciate what can be achieved.
York, North Yorkshire, UK
